As cases of seasonal influenza surge, health officials are closely monitoring a growing threat—the potential fusion of human and bird flu strains.

The Trump administration would do well to follow the lead of Maryland, which is taking decisive action to stop the spread of ...

China has reported two more H9N2 avian flu infections in humans, both of them patients from Hunan province in the southern ...

Today the Coalition for Epidemic Preparedness Innovations (CEPI) announced an award of $5 million funding award to Ethris, a ...

Applied DNA Sciences, Inc. (NASDAQ:APDN) (”Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today issued a reminder to its shareholders to vote ahead of a reconvening of a ...

Laura is an editor and staff writer at IFLScience. She obtained her Master's in Experimental Neuroscience from Imperial ...

A report published by the Animal and Plant Health Inspection Service (APHIS) of the U.S. Department of Agriculture (USDA) details the characterization of viral sequences obtained from the milk of ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

For each protein, its corresponding RNA genomic segment is indicated, as well as its approximate molecular weight (in kDa). *Compounds identified with antiviral activity in experimental trials.

Pasteurization at 63°C and 72°C effectively inactivates influenza A viruses in milk, ensuring its safety for human consumption while viral RNA may still be detected.

When the H5N1 bird flu virus jumps from animals into people, it hits a dead end. Missing the key genes that would help it infect humans, it isn’t causing a pandemic. But if the virus suddenly ...

A recent study published in Nature Communications by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) and collaborators evaluated a replicating RNA (repRNA) vaccine ...